Ndukwe, E.; Lotan, P.; Risk, M.; Koehne, E.L.; Shapiro, D.D.; Tyllo, R.P.; Allen, G.O.; Abel, E.J.; Jarrard, D.F.; Richards, K.A.
Statins Are Not Associated with Improved Bladder Cancer Outcomes in Patients with Early-Stage Bladder Cancer Treated with BCG Immunotherapy. Cancers 2025, 17, 2027.
https://doi.org/10.3390/cancers17122027
AMA Style
Ndukwe E, Lotan P, Risk M, Koehne EL, Shapiro DD, Tyllo RP, Allen GO, Abel EJ, Jarrard DF, Richards KA.
Statins Are Not Associated with Improved Bladder Cancer Outcomes in Patients with Early-Stage Bladder Cancer Treated with BCG Immunotherapy. Cancers. 2025; 17(12):2027.
https://doi.org/10.3390/cancers17122027
Chicago/Turabian Style
Ndukwe, Estelle, Paz Lotan, Michael Risk, Elizabeth L. Koehne, Daniel D. Shapiro, Robert P. Tyllo, Glenn O. Allen, E. Jason Abel, David F. Jarrard, and Kyle A. Richards.
2025. "Statins Are Not Associated with Improved Bladder Cancer Outcomes in Patients with Early-Stage Bladder Cancer Treated with BCG Immunotherapy" Cancers 17, no. 12: 2027.
https://doi.org/10.3390/cancers17122027
APA Style
Ndukwe, E., Lotan, P., Risk, M., Koehne, E. L., Shapiro, D. D., Tyllo, R. P., Allen, G. O., Abel, E. J., Jarrard, D. F., & Richards, K. A.
(2025). Statins Are Not Associated with Improved Bladder Cancer Outcomes in Patients with Early-Stage Bladder Cancer Treated with BCG Immunotherapy. Cancers, 17(12), 2027.
https://doi.org/10.3390/cancers17122027